Veru - 36 Year Stock Price History | VERU
Historical daily share price chart and data for Veru since 1990 adjusted for splits and dividends. The latest closing stock price for Veru as of February 09, 2026 is 2.39.
- The all-time high Veru stock closing price was 248.82 on January 21, 1992.
- The Veru 52-week high stock price is 7.40, which is 209.6% above the current share price.
- The Veru 52-week low stock price is 2.10, which is 12.1% below the current share price.
- The average Veru stock price for the last 52 weeks is 4.23.
| Veru Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 2.4769 | 2.2700 | 2.8000 | 2.2400 | 2.3900 | 11.68% |
| 2025 | 4.7488 | 6.5180 | 12.8000 | 2.1400 | 2.1400 | -67.10% |
| 2024 | 8.2555 | 7.2160 | 17.9000 | 3.7000 | 6.5050 | -9.65% |
| 2023 | 17.9230 | 51.4000 | 64.1000 | 6.7300 | 7.2000 | -86.36% |
| 2022 | 99.2708 | 62.1000 | 237.8000 | 15.0100 | 52.8000 | -10.36% |
| 2021 | 92.1058 | 80.5000 | 207.8000 | 58.9000 | 58.9000 | -31.91% |
| 2020 | 35.5715 | 34.6000 | 99.9000 | 23.6000 | 86.5000 | 158.21% |
| 2019 | 18.6609 | 14.0000 | 33.5000 | 12.0000 | 33.5000 | 139.29% |
| 2018 | 16.8944 | 14.3000 | 22.9000 | 11.9000 | 14.0000 | 22.81% |
| 2017 | 12.4898 | 9.2000 | 28.4000 | 9.2000 | 11.4000 | 25.27% |
| 2016 | 13.6043 | 14.5000 | 26.5000 | 8.2000 | 9.1000 | -37.24% |
| 2015 | 23.1146 | 39.0000 | 39.2000 | 13.2000 | 14.5000 | -63.01% |
| 2014 | 54.8750 | 82.9539 | 83.3499 | 33.2000 | 39.2000 | -53.41% |
| 2013 | 84.1819 | 70.6843 | 98.3169 | 65.2129 | 84.1418 | 21.36% |
| 2012 | 57.6676 | 44.2168 | 79.1078 | 44.2168 | 69.3324 | 64.10% |
| 2011 | 43.6427 | 52.3620 | 53.6436 | 35.6920 | 42.2496 | -18.89% |
| 2010 | 51.2455 | 43.7015 | 66.8337 | 40.0977 | 52.0873 | 21.71% |
| 2009 | 42.5296 | 35.8298 | 69.2167 | 25.9676 | 42.7967 | 33.24% |
| 2008 | 23.9978 | 23.0731 | 33.6583 | 17.6435 | 32.1202 | 36.02% |
| 2007 | 20.7237 | 13.7529 | 32.5726 | 13.2100 | 23.6151 | 69.48% |
| 2006 | 13.1917 | 15.3815 | 16.1053 | 10.7670 | 13.9338 | -10.46% |
| 2005 | 15.2869 | 17.6435 | 19.0007 | 11.9433 | 15.5624 | -14.00% |
| 2004 | 22.2724 | 24.4294 | 31.6678 | 13.5719 | 18.0959 | -27.27% |
| 2003 | 17.4390 | 14.4767 | 25.6961 | 12.6671 | 24.8818 | 77.42% |
| 2002 | 13.6062 | 6.4240 | 19.5435 | 6.3336 | 14.0243 | 106.67% |
| 2001 | 5.0084 | 4.2412 | 7.2383 | 3.1102 | 6.7860 | 60.00% |
| 2000 | 6.4633 | 10.1789 | 11.3099 | 3.3930 | 4.2412 | -60.53% |
| 1999 | 10.6272 | 14.1374 | 17.5304 | 6.2205 | 10.7444 | -17.39% |
| 1998 | 22.6153 | 31.1023 | 32.7988 | 11.3099 | 13.0064 | -58.93% |
| 1997 | 27.9216 | 35.0607 | 39.0192 | 15.2684 | 31.6678 | -13.85% |
| 1996 | 43.1424 | 29.9713 | 59.3771 | 24.3163 | 36.7572 | 38.30% |
| 1995 | 35.5298 | 41.5639 | 58.8116 | 23.7508 | 26.5783 | -34.27% |
| 1994 | 94.4484 | 101.7890 | 135.7190 | 35.0607 | 40.4330 | -59.37% |
| 1993 | 121.9682 | 123.2780 | 160.6010 | 92.7413 | 99.5273 | -16.98% |
| 1992 | 162.5712 | 151.5530 | 248.8180 | 90.4793 | 119.8850 | -20.90% |
| 1991 | 63.4136 | 35.6262 | 152.6840 | 32.7988 | 151.5530 | 325.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.038B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |